A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).

K. K. Ang; Q. E. Zhang; D. I. Rosenthal; P. Nguyen-Tan; E. J. Sherman; R. S. Weber; J. M. Galvin; D. L. Schwartz; A. K. El-Naggar; M. L. Gillison; R. Jordan; M. A. List; A. A. Konski; W. L. Thorstad; A. Trotti; J. J. Beitler; A. S. Garden; W. J. Spanos; S. S. Yom; R. S. Axelrod

doi:10.1200/jco.2011.29.15_suppl.5500

A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.5500 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 5500-5500 ◽

Cited By ~ 95

Author(s):

K. K. Ang ◽

Q. E. Zhang ◽

D. I. Rosenthal ◽

P. Nguyen-Tan ◽

E. J. Sherman ◽

...

Keyword(s):

Head And Neck ◽

Squamous Cell ◽

Squamous Cell Carcinomas ◽

Phase Iii ◽

Stage Iii ◽

Phase Iii Trial

Download Full-text

OC-009: Update of the randomised phase III trial DAHANCA 19: Primary C-RT or RT and zalutumumab for squamous cell carcinomas of head and neck

Radiotherapy and Oncology ◽

10.1016/s0167-8140(15)34769-1 ◽

2015 ◽

Vol 114 ◽

pp. 10 ◽

Cited By ~ 5

Author(s):

J.G. Eriksen ◽

C. Maare ◽

J. Johansen ◽

H. Primdahl ◽

J. Evensen ◽

...

Keyword(s):

Head And Neck ◽

Squamous Cell ◽

Squamous Cell Carcinomas ◽

Phase Iii ◽

Phase Iii Trial

Download Full-text

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional chemo-radiotherapy for locally advanced (LA) head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial

Annals of Oncology ◽

10.1093/annonc/mdy287.010 ◽

2018 ◽

Vol 29 ◽

pp. viii376

Author(s):

Y. Tao ◽

A. Auperin ◽

P. Blanchard ◽

M. Alfonsi ◽

X.-S. Sun ◽

...

Keyword(s):

Head And Neck ◽

Squamous Cell ◽

Dose Escalation ◽

Locally Advanced ◽

Intensity Modulated Radiotherapy ◽

Squamous Cell Carcinomas ◽

Phase Iii ◽

Phase Iii Trial ◽

Intensity Modulated

Download Full-text

Afatinib Versus Methotrexate (Mtx) As Second-Line Treatment for Patients with Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Who Progressed After Platinum-Based Therapy: Primary Efficacy Results of Lux-Head & Neck 1, a Phase III Trial

Annals of Oncology ◽

10.1093/annonc/mdu438.30 ◽

2014 ◽

Vol 25 ◽

pp. v1 ◽

Cited By ~ 3

Author(s):

J-P. Machiels ◽

R.I. Haddad ◽

J. Fayette ◽

L.F. Licitra ◽

M. Tahara ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase Iii ◽

Line Treatment ◽

Second Line ◽

Primary Efficacy ◽

Phase Iii Trial ◽

Head Neck

Download Full-text

Impact of Primary Site of Stage III and IV Squamous Cell Carcinomas of the Head and Neck on 7-Year Survival Figures Following Initial Non-Cisplatin-Containing Combination Chemotherapy

Preoperative (Neoadjuvant) Chemotherapy - Recent Results in Cancer Research ◽

10.1007/978-3-642-82671-9_14 ◽

1993 ◽

pp. 124-134 ◽

Cited By ~ 6

Author(s):

L. A. Price ◽

B. T. Hill

Keyword(s):

Head And Neck ◽

Squamous Cell ◽

Combination Chemotherapy ◽

Squamous Cell Carcinomas ◽

Primary Site ◽

Stage Iii

Download Full-text

1 A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: Preliminary results of RTOG 9003

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(99)90019-6 ◽

1999 ◽

Vol 45 (3) ◽

pp. 145 ◽

Cited By ~ 18

Author(s):

K.K. Fu ◽

T.F. Pajak ◽

A. Trotti ◽

S.A. Spencer ◽

C.U. Jones ◽

...

Keyword(s):

Radiation Therapy ◽

Head And Neck ◽

Squamous Cell ◽

Randomized Study ◽

Radiation Therapy Oncology Group ◽

Squamous Cell Carcinomas ◽

Phase Iii ◽

Oncology Group ◽

Accelerated Fractionation ◽

Standard Fractionation

Download Full-text

A Radiation Therapy Oncology Group (RTOG) phase III randomised study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas; first report of RTOG 9003

Cancer/Radiothérapie ◽

10.1016/s1278-3218(00)00060-3 ◽

2001 ◽

Vol 5 (1) ◽

pp. 95-96 ◽

Cited By ~ 1

Author(s):

K.K Fu ◽

T.F Pajak ◽

A Trotti ◽

C.U Jones ◽

S.A Spencer ◽

...

Keyword(s):

Radiation Therapy ◽

Head And Neck ◽

Squamous Cell ◽

Radiation Therapy Oncology Group ◽

Squamous Cell Carcinomas ◽

Phase Iii ◽

Oncology Group ◽

Randomised Study ◽

Accelerated Fractionation ◽

Standard Fractionation

Download Full-text

Induction docetaxel platinum 5-FU (TPF) followed by cetuximab-radiotherapy (cetux-RT) versus concurrent chemo-radiotherapy (CT/RT) in patients with N2b/c-N3 non operated stage III-IV squamous cell cancer of the head and neck (SCCHN): Results of the GORTEC 2007-02 phase III randomized trial.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.6000 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 6000-6000 ◽

Cited By ~ 19

Author(s):

Lionnel Geoffrois ◽

Laurent Martin ◽

Pascal Garaud ◽

Dominique De Raucourt ◽

Joelle Miny ◽

...

Keyword(s):

Randomized Trial ◽

Head And Neck ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Phase Iii ◽

Stage Iii

Download Full-text

Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent

Radiotherapy and Oncology ◽

10.1016/j.radonc.2011.06.025 ◽

2011 ◽

Vol 100 (1) ◽

pp. 70-75 ◽

Cited By ~ 51

Author(s):

Jacques Tortochaux ◽

Yungan Tao ◽

Elodie Tournay ◽

Michel Lapeyre ◽

Francois Lesaunier ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma ◽

Phase Iii ◽

Second Primary ◽

Phase Iii Trial ◽

Palliative Intent

Download Full-text

Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-11-2295 ◽

2011 ◽

Vol 18 (1) ◽

pp. 301-307 ◽

Cited By ~ 34

Author(s):

Annette M. Lim ◽

Danny Rischin ◽

Richard Fisher ◽

Hongbin Cao ◽

Kathleen Kwok ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Prognostic Significance ◽

Neck Squamous Cell Carcinoma ◽

Phase Iii ◽

Advanced Head ◽

Phase Iii Trial

Download Full-text

A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard- fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to fu et al. IJROBP 2000;48:7–16

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(01)01661-3 ◽

2001 ◽

Vol 51 (2) ◽

pp. 563 ◽

Cited By ~ 2

Author(s):

Hans-Hermann Dubben ◽

Hans-Peter Beck-Bornholdt

Keyword(s):

Radiation Therapy ◽

Head And Neck ◽

Squamous Cell ◽

Randomized Study ◽

Radiation Therapy Oncology Group ◽

Squamous Cell Carcinomas ◽

Phase Iii ◽

Oncology Group ◽

Accelerated Fractionation ◽

Standard Fractionation

Download Full-text